MUSTANG BIO, INC. — Director's Dealing 2018

Dec 3, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: MUSTANG BIO, INC. (MBIO)
CIK: 0001680048
Period of Report: 2018-02-02

Reporting Person: Achenbach Brian (VP, Fin. & Corp. Controller)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-02-02	COMMON STOCK	A	55000	—	Acquired	55000	Direct
2018-11-16	COMMON STOCK	P	1000	$4.31	Acquired	56000	Direct
2018-11-19	COMMON STOCK	P	1000	$4.25	Acquired	57000	Direct
2018-11-20	COMMON STOCK	P	500	$3.8742	Acquired	57500	Direct

Footnotes

F1: 55,000 shares are restricted Common Stock which vest over various time periods.

F2: Reflects the weighted average purchase price of multiple same-way open market purchase transactions effected by the Reporting Person on the same day at different prices through a purchase order executed by a broker-dealer. The reporting person reported on a single line all such transactions that occurred within a one dollar price range. The range of prices for the purchase transactions on November 16, 2018 was $4.15 to $4.3792, and the range of prices for the purchase transactions on November 19, 2018 was $4.15 to $4.35. The reporting person hereby undertakes to provide upon request by the Securities Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares purchased at each separate price.